S2-E60 - Explore Major Upcoming Events and Issues for NAFLD and NASH At Our NASH-TAG 2022 Preview
Send us Fan Mail NASH-TAG 2022 Co-chair Stephen Harrison and Steering Committee Member Jörn Schattenberg review the upcoming conference, focusing on major issues in NAFLD and NASH diagnosis, staging, ...
9 Joulu 202149min
S2-E59.4 - What Can We Do To Reshape a Potentially Disasatrous Growth in Cirrhosis?
Send us Fan Mail Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell, and Roger Green to discuss the groundbreaking paper "Advancing the Global Health Ag...
5 Joulu 202115min
S2-E59.3 - What's next in Driving the Global Health Agenda for NAFLD?
Send us Fan Mail Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell, and Roger Green to discuss the groundbreaking paper "Advancing the Global Health Ag...
5 Joulu 202115min
S2-E59.2 - Key Issues For the NAFLD Global Health Agenda: Prevalence and Cost Data
Send us Fan Mail Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell, and Roger Green to discuss the groundbreaking paper "Advancing the Global Health Ag...
4 Joulu 202113min
S2-E59.1 - How the global Health Agenda for NAFLD Was Developed
Send us Fan Mail Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell and Roger Green to discuss the groundbreaking paper "Advancing the Global Health Age...
4 Joulu 202112min
S2-E59 - Discuss the Global NAFLD Agenda publication With Lead Author Jeffrey Lazarus
Send us Fan Mail Lead author Jeffrey Lazarus joins the Surfers to discuss Advancing the Global Public Health Agenda for NAFLD, the major article recently published in Nature Reviews Gastroenterology a...
2 Joulu 20211h 1min
S2-E58.3 - Focus On NASH Cirrhosis: Trials in Process and a Plea For MRE
Send us Fan Mail This episode follows S2 E43 in discussing the possible role of NASH cirrhosis clinical trials in the transition from biopsy as gold standard to a post-biopsy world. Terns Pharma CEO S...
28 Marras 202121min
S2-E58.2 - Focus On NASH Cirrhosis: Reviewing FALCON 2 and the Belapectin Post Hoc Analysis of Phase 2 Data
Send us Fan Mail This episode follows S2 E43 in discussing the possible role of NASH cirrhosis clinical trials in the transition from biopsy as gold standard to a post-biopsy world. Stephen Harrison s...
27 Marras 202116min
